| Authors: |
Maruyama Y; Department of Clinical Immuno Oncology, Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan; Division of Medical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan; Pharmacological Research Center, Showa Medical University, Tokyo, Japan; Department of Otorhinolaryngology-Head and Neck Surgery, Showa Medical University School of Medicine, Tokyo, Japan., Hosonuma M; Department of Clinical Immuno Oncology, Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan; Division of Medical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan; Pharmacological Research Center, Showa Medical University, Tokyo, Japan; Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan., Toyoda H; Department of Clinical Immuno Oncology, Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan; Division of Medical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan; Pharmacological Research Center, Showa Medical University, Tokyo, Japan; Department of Orthopaedic Surgery, School of Medicine, Showa Medical University, Tokyo, Japan., Funayama E; Department of Clinical Immuno Oncology, Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan; Pharmacological Research Center, Showa Medical University, Tokyo, Japan; Division of Pharmacology, Department of Pharmacology, Toxicology and Therapeutics, School of Pharmacy, Showa Medical University, Tokyo, Japan., Sasaki A; Division of Medical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan; Pharmacological Research Center, Showa Medical University, Tokyo, Japan., Baba Y; Department of Clinical Immuno Oncology, Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan., Tajima K; Department of Clinical Immuno Oncology, Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan., Nakashima R; Department of Clinical Immuno Oncology, Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan., Sasaki A; Department of Clinical Immuno Oncology, Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan; Division of Medical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan; Pharmacological Research Center, Showa Medical University, Tokyo, Japan., Shida M; Department of Clinical Immuno Oncology, Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan., Tsurui T; Department of Clinical Immuno Oncology, Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan; Division of Medical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan; Pharmacological Research Center, Showa Medical University, Tokyo, Japan; Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan., Tsuji M; Pharmacological Research Center, Showa Medical University, Tokyo, Japan., Tsunoda T; Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan., Shimane T; Department of Clinical Immuno Oncology, Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan; Head and Neck Oncology Center, Showa Medical University, Tokyo, Japan., Kiuchi Y; Division of Medical Pharmacology, Department of Pharmacology, Showa Medical University School of Medicine, Tokyo, Japan; Pharmacological Research Center, Showa Medical University, Tokyo, Japan., Yoshimura K; Department of Clinical Immuno Oncology, Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan; Division of Medical Oncology, Department of Medicine, Showa Medical University School of Medicine, Tokyo, Japan., Kuramasu A; Department of Clinical Immuno Oncology, Research Institute for Clinical Pharmacology and Therapeutics, Showa Medical University, Tokyo, Japan. Electronic address: atsuok@med.showa-u.ac.jp. |
